DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

03.11.25 08:37 Uhr

Werte in diesem Artikel
Aktien

51,79 EUR 1,28 EUR 2,53%

LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

(PRNewsfoto/The Schall Law Firm)

Investors who purchased the Company's securities between January 8, 2024 and July 25, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 21, 2024.       

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. DexCom's communications about growth and anticipated margins were unreasonably optimistic due to its reliance on attracting new customers. The Company was struggling to keep existing distribution channels successful. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about DexCom, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dxcm-investors-have-opportunity-to-lead-dexcom-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302601999.html

SOURCE The Schall Law Firm

In eigener Sache

Übrigens: DexCom und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf DexCom

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DexCom

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu DexCom Inc.

Wer­bung

Analysen zu DexCom Inc.

DatumRatingAnalyst
02.08.2018DexCom BuyCanaccord Adams
03.05.2018DexCom BuyCanaccord Adams
23.03.2018DexCom OutperformRobert W. Baird & Co. Incorporated
28.09.2017DexCom OutperformWedbush Morgan Securities Inc.
15.09.2017DexCom Equal WeightBarclays Capital
DatumRatingAnalyst
02.08.2018DexCom BuyCanaccord Adams
03.05.2018DexCom BuyCanaccord Adams
23.03.2018DexCom OutperformRobert W. Baird & Co. Incorporated
28.09.2017DexCom OutperformWedbush Morgan Securities Inc.
03.05.2017DexCom BuyCanaccord Adams
DatumRatingAnalyst
15.09.2017DexCom Equal WeightBarclays Capital
30.04.2015DexCom PerformOppenheimer & Co. Inc.
27.01.2015DexCom PerformOppenheimer & Co. Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DexCom Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen